Atm^tm1Gct

The targeting construct introduced a neomycin resistance cassette with FRT inserted into intron 51 and a modified exon 51 with the mouse mutation corresponding to the human disease associated mutation T7271G mutation. The resulting amino acid substitution corresponds to the human substitution from valine to glycine (V2424G). (J:104190)